INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Quarterly Results

Change Company Name

Aurobindo Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 524804	ISIN Demat INE406A01037	Book Value 369.16	NSE Symbol AUROPHARMA	Dividend Yield (%) 0	Market Cap (₹ Cr.) 69,330.29	P/E 34.31	EPS 34.79	Face Value 1

Particulars (₹ Cr)	Sep 2025	Jun 2025	Mar 2025	Dec 2024

Gross Sales/Income from operations	2759.89	2822.14	2721.43	2883.56
Less: Excise duty	0.00	0.00	0.00	0.00
Net Sales/Income from operations	2,759.89	2,822.14	2,721.43	2,883.56
Other Operating Income	29.83	26.03	10.56	33.07
Total Income from operations (net)	2,789.72	2,848.17	2,731.99	2,916.63
Total Expenses	2,136.51	2,121.85	2,229.36	2,271.76
Cost of Sales	1,367.58	1,392.87	1,437.53	1,464.28
Employee Cost	294.37	282.97	273.11	265.15
Depreciation, amortization and depletion expense	71.49	70.02	93.88	68.28
Provisions & Write Offs	0.00	0.00	0.00	0.00
Administrative and Selling Expenses	0.00	0.00	0.00	0.00
Other Expenses	403.07	375.99	424.84	474.05
Pre Operation Expenses Capitalised	0.00	0.00	0.00	0.00
Profit from operations before other income, finance costs and exceptional items	653.21	726.32	502.63	644.87
Other Income	159.52	83.77	113.98	54.26
Profit from ordinary activities before finance costs and exceptional items	812.73	810.09	616.61	699.13
Finance Costs	57.45	60.00	61.09	66.19
Profit from ordinary activities after finance costs but before exceptional items	755.28	750.09	555.52	632.94
Exceptional Items	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00
Profit from ordinary activities before tax	755.28	750.09	555.52	632.94
Total Tax	173.91	190.96	147.35	160.89
Net profit from Ordinary Activities After Tax	581.37	559.13	408.17	472.05
Profit / (Loss) from Discontinued Operations	0.00	0.00	0.00	0.00
Net profit from Ordinary Activities/Discontinued Operations After Tax	581.37	559.13	408.17	472.05
Extraordinary items	0.00	0.00	0.00	0.00
Other Adjustments After Tax	0.00	0.00	0.00	0.00
Net Profit after tax for the Period	581.37	559.13	408.17	472.05
Other Comprehensive Income	-0.03	-1.32	-0.91	-1.45
Total Comprehensive Income	581.34	557.81	407.26	470.60
Equity	58.08	58.08	58.08	58.08
Reserve & Surplus	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00
EPS:
EPS before Exceptional/Extraordinary items-Basic	10.10	9.63	7.03	8.13
EPS before Exceptional/Extraordinary items-Diluted	10.10	9.63	7.03	8.13
EPS after Exceptional/Extraordinary items-Basic	10.10	9.63	7.03	8.13
EPS after Exceptional/Extraordinary items-Diluted	10.10	9.63	7.03	8.13
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00
Dividend Per Share(Rs.)	0.00	4.00	0.00	0.00
Dividend (%)	0.00	400.00	0.00	0.00
No. of Employees	0.00	0.00	0.00	0.00
Debt Equity Ratio	0.00	0.00	0.00	0.00
Debt Service Coverage Ratio	0.00	0.00	0.00	0.00
Interest Service Coverage Ratio	0.00	0.00	0.00	0.00
Debenture Redemption Reserve (Rs cr)	0.00	0.00	0.00	0.00
Paid up Debt Capital (Rs cr)	0.00	0.00	0.00	0.00